Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
Aiforia and PathAI will integrate Aiforia’s AI pathology models into the AISight Dx platform. The integration is meant to expand access to digital pathology tools in the US and Europe.
Read the original →A two-stage deep learning framework can automatically segment subpleural lung lesions on grayscale ultrasound. It distinguishes benign from malignant cases and significantly improves diagnostic accuracy.
Read the original →Researchers in China have built a deep-learning model that fuses CT, MRI, and 3D radiation dose data. The model predicts which nasopharyngeal carcinoma patients will develop life-threatening tissue necrosis.
Read the original →Capital markets are changing how they assess South Korean medical AI companies. A few years ago, overseas regulatory milestones such as U.S. FDA authorizations and European CE marking, along with supply contracts with major hospitals, were considered key drivers of share prices.
Read the original →The authors define TechBio 3.0 as an emerging paradigm for closed-loop drug discovery that connects multimodal molecular representations, generative chemistry, and automated experimentation. They examine early preclinical and clinical evidence and identify remaining technical and translational barriers.
Read the original →Lonza has entered a collaboration with biotechnology startup Onava. The aim is to accelerate the development of AI-designed biologic drugs.
Read the original →The listings include jobs designing jewelry with AI, launching a professional soccer team and managing a 100-unit affordable housing community in Newark. All can be applied for in New Jersey this week.
Read the original →Researchers at ETH Zurich and Roche combined active learning with geometric and self-supervised deep learning. The approach predicts C–H borylation regioselectivity in drug-like molecules.
Read the original →The AI in healthcare market is projected to grow $39.93 billion at a CAGR of 34% from 2025 to 2030, driven by the proliferation of big data and the increasing complexity of healthcare datasets.
Read the original →An analysis of code availability in the open-access published literature shows that code sharing in clinical prediction models remains limited. It also reveals significant variability in practices and documentation quality.
Read the original →A clinical trial in the United States showed that an AI chatbot can assist doctors during consultations. It can give information on symptoms and possible diagnoses before patients meet a medical professional in person. Experts stress that the technology cannot yet fully replace doctors' roles and still requires close supervision.
Read the original →Ubie Inc. issued a press release on October 9, 2026, at 11:00. It announced that Kanazawa Medical University Hospital has begun full use of Ubie generative AI in its electronic medical record environment.
Read the original →